Nuvation Bio Common Stock

Nuvation Bio (NUVB) currently reports a common stock of $1.4B as of June 2026. That compares with $1.4B in the prior-year period — up 2.4% year over year. Use the charts on this page to explore Nuvation Bio's common stock history and peer comparisons.

Nuvation Bio's common stock increased from $1.4B to $1.4B — a 2.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvation Bio reported $1.4B in common stock as of June 2026. That compares with $1.4B in the prior-year period — up 2.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $1.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvation Bio, and consider following NUVB for alerts when major investors trade the stock.

Nuvation Bio is classified in the Healthcare sector. On common stock, it currently shows $1.4B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NUVB with unrelated industries.